Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    - Revision: v3.3.2 was added, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T21:09:53.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The government funding operating-status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T19:04:34.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    No significant changes observed on the page; the study details and overall presentation remain the same between versions.
    Difference
    0.4%
    Check dated 2025-10-28T02:29:22.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    2%
    Check dated 2025-10-06T15:52:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T09:49:28.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock, or other critical data.
    Difference
    0.1%
    Check dated 2025-09-14T23:49:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.